CDC’s “Our Global Voices”: Vaccination remains the most cost-effective strategy to get on track with hepatitis B elimination in resource-limited settings
Rania Tohme, team lead at the CDC’s Global Immunization Division, discusses global efforts to address hepatitis B and the challenges facing vaccine accessibility and delivery in resource-limited settings. “At the moment, the most cost-effective approach in resource-limited settings is provision of the hepatitis B vaccine birth dose followed by 2-3 additional doses of pentavalent vaccine. … [M]ore efforts are needed to promote hepatitis B vaccine birth dose introduction and increase vaccination in Africa and Asia. CDC’s commitment to collaborating with global partners to eliminate hepatitis B will continue to contribute to the impact of hepatitis B vaccination,” she writes (7/27).